Inbest Prime II to Vote on Move From BME Growth to BME Scaleup
Inbest Prime II will submit its move from BME Growth to BME Scaleup for ratification on November 23.
Related stories
JPMorgan Initiates Palantir Coverage With Overweight Rating, $262 Target
JPMorgan initiated research coverage of Palantir with an overweight rating and a $262 12-month price target, 33% above Wednesday’s level.
M impact | EQUITY | Oct 30, 2026, 01:22 AM UTC
Novatti Group Reports Quarterly Revenue of A$6.9 Million
Novatti Group reported quarterly group revenue of A$6.9 million.
M impact | EQUITY | Oct 30, 2026, 01:21 AM UTC
Hang Seng Index Opens 0.2% Higher at 23011.29
L impact | EQUITY | Oct 30, 2026, 01:21 AM UTC
X2M Connect Secures A$1.4M for Data Centre and AI Strategy
M impact | EQUITY | Oct 30, 2026, 01:21 AM UTC
X2M Connect Secures A$1.4 Million for Data Centre and AI Strategy
M impact | EQUITY | Oct 30, 2026, 01:21 AM UTC
Zhongji Innolight Hong Kong shares open 7.2% lower, hit record low
Hong Kong-listed Zhongji Innolight shares opened 7.2% lower, reaching their lowest level since listing.
M impact | EQUITY | Oct 30, 2026, 01:21 AM UTC